Multiplex PCR and Pooled Susceptibility Testing for Polymicrobial UTIs
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for managing urinary tract infections (UTIs) face challenges due to innate and acquired antibiotic resistance, where the detection of antibiotic resistance genes does not guarantee antibiotic susceptibility, and traditional urine culture methods fail to detect polymicrobial infections and antibiotic resistance accurately, leading to inappropriate treatment.
Innovation Solution
The use of multiplex PCR-based methods for detecting bacteria and pooled antibiotic susceptibility testing (P-AST) to identify polymicrobial infections and determine effective therapeutic solutions by analyzing the concordance between antibiotic resistance genes and susceptibility, allowing for rapid identification and treatment of UTIs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional urine culture methods are used, then the process is simple and familiar, but polymicrobial infections and antibiotic resistance cannot be detected accurately
Solution Approach 1:
The patent combines multiple detection functions into a single testing system that simultaneously identifies multiple bacterial species and tests antibiotic susceptibility. The pooled antibiotic susceptibility testing (P-AST) method allows concurrent evaluation of multiple organisms against multiple antibiotics without requiring separate cultures for each pathogen, thereby achieving high detection accuracy while managing complexity through integrated assay design.
Solution Approach 2:
The testing system is designed to perform multiple functions: identifying polymicrobial infections, detecting antibiotic resistance genes, and determining susceptibility profiles all within a single platform. The assay can detect various bacterial types (Gram-positive, Gram-negative, fastidious organisms) and test against multiple antibiotic classes, providing universal applicability across different infection scenarios without requiring method切换.
2Loss of information
If antibiotic resistance genes are detected, then genetic information is obtained, but susceptibility to antibiotics cannot be guaranteed
Solution Approach 1:
The system incorporates phenotypic susceptibility testing as feedback to validate and refine predictions based on genotypic data. By measuring actual bacterial response to antibiotics in the pooled susceptibility assay, the system adjusts and confirms resistance predictions, ensuring that final susceptibility determinations are reliable regardless of initial genetic markers detected.
Solution Approach 2:
The patent uses a composite approach combining genotypic data (antibiotic resistance gene detection) with phenotypic data (actual susceptibility testing results) to form a comprehensive resistance profile. This composite methodology integrates multiple information sources to overcome the limitations of either approach alone, providing both complete information and high reliability in susceptibility prediction.
3Loss of time
If rapid identification of polymicrobial infections is achieved, then treatment time is reduced, but testing complexity increases
Solution Approach 1:
The system performs preliminary pooling of bacterial samples before susceptibility testing, creating concentrated samples that enhance detection sensitivity and reduce testing steps. By pre-concentrating and pooling organisms from clinical specimens, the method accelerates identification while managing complexity through standardized pool preparation protocols that can be automated.
Solution Approach 2:
The patent replaces traditional mechanical culture methods with molecular detection techniques (PCR-based identification) and pooled susceptibility assays. This substitution eliminates time-consuming culture growth steps while using biochemical and genetic detection methods that provide rapid results, reducing treatment delay despite increased analytical complexity that is managed through automated systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables accurate detection of polymicrobial infections and determination of effective antibiotic treatments, improving treatment outcomes by considering the interactions between cohabiting bacterial species and reducing the risk of antibiotic resistance.
Implementation Method 1
utilize tests including but not limited to those identifying genetic information such as the presence or absence of particular antibiotic resistance genes
Implementation Method 2
pooled antibiotic susceptibility testing (P-AST) to identify polymicrobial infections and determine effective therapeutic solutions by analyzing the concordance between antibiotic resistance genes and susceptibility
Data Source
AI summary
Methods for identifying and providing therapeutic solutions for treating polymicrobial infections, such as but not limited to urinary tract infections, based on concordance between ABR genes and antibiotic susceptibility. The methods herein feature detection and identification of organisms of the polymicrobial infection, phenotypic pooled sensitivity tests for determining the susceptibility or resistance of the polymicrobial infection in the sample to an antibiotic or other therapeutic agent, and identification of resistance genes, e.g., genetic markers that may indicate resistance to a particular treatment. Together, the data can be applied against databases of antibiotic/therapeutic susceptibility or resistance for particular known polymicrobial infections in order to provide one or more therapeutic solutions for the polymicrobial infection.